Search for: "Teva Pharmaceuticals" Results 261 - 280 of 1,422
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Jul 2017, 12:47 pm by George L. Kanabe
  On July 7, 2017, Teva Pharmaceuticals USA, Inc. filed a complaint in the Eastern District of Pennsylvania alleging that a former executive disclosed confidential information to a romantic partner who happens to be an executive of one of Teva’s direct competitors. [read post]
20 Jul 2017, 12:47 pm by George L. Kanabe
  On July 7, 2017, Teva Pharmaceuticals USA, Inc. filed a complaint in the Eastern District of Pennsylvania alleging that a former executive disclosed confidential information to a romantic partner who happens to be an executive of one of Teva’s direct competitors. [read post]
21 Jul 2008, 3:31 am
Teva announced Friday that it is acquiring Barr Pharmaceuticals for $7.5 billion plus $1.5 billion in debt. [read post]
Just last month a New York jury found opioid manufacturer Teva Pharmaceuticals USA liable for public nuisance after it inundated the state with pills, killing thousands of people. [read post]
5 Jan 2010, 8:50 pm by Patent Docs
By Suresh Pillai -- The Medicines Company Files New Lawsuits in Angiomax® Patent Dispute Following up on lawsuits filed in October against defendant Teva Pharmaceuticals, The Medicines Company has now filed new lawsuits alleging infringement of U.S. [read post]
12 Oct 2018, 1:24 pm by Lawrence B. Ebert
Delaware of invalidity of claims:Plaintiffs-Appellants Teva Pharmaceuticals USA,Inc., Teva Pharmaceutical Industries, Ltd., Teva Neuroscience,Inc., and Yeda Research and Development Co. [read post]
30 Aug 2018, 6:34 am
In a forthcoming article, we tell the story of our class action against Teva Pharmaceutical Industries as an illustration of the global race to laxity in the regulation of capital markets. [read post]
19 Sep 2008, 4:54 am
The 20-page report, entitled "Stimulating Innovation in the Biologics Industry: A Balanced Approach to Marketing Exclusivity," was funded by Teva Pharmaceuticals USA (see Teva press release). [read post]
14 Oct 2009, 9:21 pm
District Court for the Southern District of New York by Gilead Sciences Inc. over alleged patent infringement, Teva Pharmaceuticals has filed an amended answer and counterclaim alleging that the patents-in-suit are invalid. [read post]
11 Sep 2012, 5:30 am by Gene Quinn
Teva Sues Mylan Over Multiple Sclerosis Drug COPAXONE®Teva Pharmaceutical Industries Ltd. issued a press release last week discussing the abbreviated new drug application (ANDA) containing a Paragraph IV certification for COPAXONE® (glatiramer acetate injection), filed by Mylan Pharmaceuticals Inc. [read post]
21 Apr 2008, 9:11 pm
Patent Nos. 4,628,098, covering the lansoprazole compound, and 5,045,321, covering a pharmaceutical composition of lansoprazole, against Teva. [read post]
20 Jan 2015, 8:48 am by Jason Rantanen
By Jason Rantanen Teva Pharmaceuticals USA, Inc. v. [read post]
27 Jul 2014, 9:38 pm by Patent Docs
• Defendant: Teva Pharmaceuticals USA Inc. [read post]
6 Mar 2017, 9:00 am by Brianna Smith
From Mylan and their Epipen fiasco to Teva Pharmaceutical Industries Ltd, consumers are wondering when someone will step in to make this price gouging stop before drugs like the Epipen simply become unaffordable. [read post]